In our study, we identified a potential role for ALYREF in platinum resistance through reanalysis of RNA-Seq data from cisplatin-resistant ovarian cancer cell lines and single-cell sequencing data from patient samples. This evidence concerns the gene ALYREF and ovarian carcinoma.